P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES

• A. Taghi Khani,
• A. Kumar,
• K. Radecki,
• S. J. Lee,
• A. Sanchez Ortiz,
• M. Lorenson,
• X. Wu,
• J. Koff,
• S. Forman,
• Z. Gu,
• A. Walker,
• S. Swaminathan

Affiliations

A. Taghi Khani

1 Systems Biology, Beckman Research Institute of City of Hope, Monrovia

A. Kumar

1 Systems Biology, Beckman Research Institute of City of Hope, Monrovia

K. Radecki

2 Biomedical Sciences, University of California Riverside, Riverside

S. J. Lee

1 Systems Biology, Beckman Research Institute of City of Hope, Monrovia

A. Sanchez Ortiz

1 Systems Biology, Beckman Research Institute of City of Hope, Monrovia

M. Lorenson

2 Biomedical Sciences, University of California Riverside, Riverside

X. Wu

3 Molecular and Cellular Biology, Beckman Research Institute of City of Hope, Duarte

J. Koff

4 Hematology and Medical Oncology, Emory University School of Medicine, Atlanta

S. Forman

5 Hematology & Hematopoietic Cell Transplantation, Beckman Research Institute of City of Hope, Duarte, United States of America

Z. Gu

1 Systems Biology, Beckman Research Institute of City of Hope, Monrovia

A. Walker

2 Biomedical Sciences, University of California Riverside, Riverside

S. Swaminathan

1 Systems Biology, Beckman Research Institute of City of Hope, Monrovia